Literature DB >> 3481178

Analysis of linear growth using a mathematical model. II. From 3 to 21 years of age.

J Karlberg1, J G Fryer, I Engström, P Karlberg.   

Abstract

The 'ICP growth model' (ICP = Infancy, Childhood and Puberty components) represents linear growth from 3 years of age to maturity by a combination of a slowly decelerating childhood component together with a sigmoid puberty component, the latter acting only during adolescence. Linear growth is analysed for 157 longitudinally followed healthy infants using this model. The main aim is to assess the ability of the ICP model to describe and evaluate individual growth patterns in healthy children with particular emphasis on the considerable individual variation in the timing of puberty and the shape of the pubertal growth spurt. The use of the model to evaluate growth longitudinally over both short and long periods is also outlined. Reference values based on the ICP approach, the ICP Standard, seem to have a number of advantages in comparison with cross-sectional standards. In the 'Prepubertal ICP Standard', the contribution of the puberty component is omitted. The standard can be applied on an individual basis to evaluate prepubertal growth and pubertal onset, independently of the timing of puberty. By using the 'Pubertal ICP Standard' both the difference in pubertal maturation and the negative relationship between the size of the pubertal gain and the timing of puberty are taken into account. The fact that the gain in the puberty component is time-invariant, and can thus be aligned with the timing of puberty for an individual child, forms the basis of this approach. The analyses have also revealed a new predictor for final height, which is termed HAPO (height adjusted for pubertal onset). This predictor is based on age and attained size at onset of puberty--the 'onset' regression line.

Entities:  

Mesh:

Year:  1987        PMID: 3481178     DOI: 10.1111/j.1651-2227.1987.tb17122.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  17 in total

1.  Management of growth failure in Crohn's disease.

Authors:  J A Walker-Smith
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

2.  Growth Disorders.

Authors:  Meena P Desai
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Short-term growth: rhythms, chaos, or noise?

Authors:  J K Wales; A T Gibson
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

Review 4.  Nutrition in infants and very young children with chronic kidney disease.

Authors:  Bethany J Foster; Lynn McCauley; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2011-08-28       Impact factor: 3.714

Review 5.  Small for gestational age: towards 2004.

Authors:  Z Zadik; O Dimant; A Zung; R Reifen
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

6.  Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity.

Authors:  B Karlsson; J Gustafsson; G Hedov; S A Ivarsson; G Annerén
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

7.  Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol.

Authors:  A A Massarano; C G Brook; P C Hindmarsh; P J Pringle; J D Teale; R Stanhope; M A Preece
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

8.  Pubarche as well as thelarche may be a marker for the onset of puberty.

Authors:  Frank M Biro; Bin Huang; Stephen R Daniels; Anne W Lucky
Journal:  J Pediatr Adolesc Gynecol       Date:  2008-12       Impact factor: 1.814

9.  Prepubertal children with short stature have a different perception of their well-being and stature than their parents.

Authors:  A Erling; I Wiklund; K Albertsson-Wikland
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

10.  Intrauterine growth and postnatal skeletal development: findings from the Southampton Women's Survey.

Authors:  Nicholas C Harvey; Pam A Mahon; Miranda Kim; Zoe A Cole; Sian M Robinson; Kassim Javaid; Hazel M Inskip; Keith M Godfrey; Elaine M Dennison; Cyrus Cooper
Journal:  Paediatr Perinat Epidemiol       Date:  2012-01       Impact factor: 3.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.